annual total liabilities:
$70.73B+$1.69B(+2.45%)Summary
- As of today (April 12, 2025), MRK annual total liabilities is $70.73 billion, with the most recent change of +$1.69 billion (+2.45%) on December 1, 2024.
- During the last 3 years, MRK annual total liabilities has risen by +$3.30 billion (+4.89%).
- MRK annual total liabilities is now at all-time high.
Performance
MRK Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$70.73B-$2.24B(-3.07%)Summary
- As of today (April 12, 2025), MRK quarterly total liabilities is $70.73 billion, with the most recent change of -$2.24 billion (-3.07%) on December 1, 2024.
- Over the past year, MRK quarterly total liabilities has stayed the same.
- MRK quarterly total liabilities is now -3.07% below its all-time high of $72.97 billion, reached on September 30, 2024.
Performance
MRK quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MRK Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.5% | 0.0% |
| 3 y3 years | +4.9% | 0.0% |
| 5 y5 years | +21.1% | 0.0% |
MRK Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.1% | -3.1% | +16.2% |
| 5 y | 5-year | at high | +21.1% | -3.1% | +23.4% |
| alltime | all time | at high | +3356.5% | -3.1% | +3356.5% |
Merck & Co Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $70.73B(+2.5%) | $70.73B(-3.1%) |
| Sep 2024 | - | $72.97B(+5.8%) |
| Jun 2024 | - | $68.98B(+5.4%) |
| Mar 2024 | - | $65.42B(-5.2%) |
| Dec 2023 | $69.04B(+9.4%) | $69.04B(+5.5%) |
| Sep 2023 | - | $65.43B(-0.5%) |
| Jun 2023 | - | $65.73B(+7.9%) |
| Mar 2023 | - | $60.89B(-3.5%) |
| Dec 2022 | $63.10B(-6.4%) | $63.10B(+0.9%) |
| Sep 2022 | - | $62.56B(-1.9%) |
| Jun 2022 | - | $63.78B(-2.9%) |
| Mar 2022 | - | $65.72B(-2.6%) |
| Dec 2021 | $67.44B(+1.9%) | $67.44B(+17.0%) |
| Sep 2021 | - | $57.63B(+0.6%) |
| Jun 2021 | - | $57.30B(-10.2%) |
| Mar 2021 | - | $63.81B(-3.6%) |
| Dec 2020 | $66.18B(+13.3%) | $66.18B(+9.3%) |
| Sep 2020 | - | $60.53B(-3.7%) |
| Jun 2020 | - | $62.87B(+7.3%) |
| Mar 2020 | - | $58.61B(+0.4%) |
| Dec 2019 | $58.40B(+4.7%) | $58.40B(+3.5%) |
| Sep 2019 | - | $56.41B(+0.3%) |
| Jun 2019 | - | $56.23B(+2.8%) |
| Mar 2019 | - | $54.68B(-1.9%) |
| Dec 2018 | $55.76B(+4.6%) | $55.76B(+6.3%) |
| Sep 2018 | - | $52.47B(+0.4%) |
| Jun 2018 | - | $52.27B(+0.3%) |
| Mar 2018 | - | $52.14B(-2.2%) |
| Dec 2017 | $53.30B(-3.2%) | $53.30B(+0.2%) |
| Sep 2017 | - | $53.18B(+0.2%) |
| Jun 2017 | - | $53.09B(-6.0%) |
| Mar 2017 | - | $56.47B(+2.5%) |
| Dec 2016 | $55.07B(-3.2%) | $55.07B(+1.3%) |
| Sep 2016 | - | $54.38B(+2.5%) |
| Jun 2016 | - | $53.03B(-3.3%) |
| Mar 2016 | - | $54.85B(-3.6%) |
| Dec 2015 | $56.91B(+15.3%) | $56.91B(+2.4%) |
| Sep 2015 | - | $55.55B(-0.7%) |
| Jun 2015 | - | $55.94B(-7.4%) |
| Mar 2015 | - | $60.43B(+22.4%) |
| Dec 2014 | $49.38B(-7.4%) | $49.38B(-12.5%) |
| Sep 2014 | - | $56.45B(+14.4%) |
| Jun 2014 | - | $49.34B(-11.7%) |
| Mar 2014 | - | $55.90B(+4.8%) |
| Dec 2013 | $53.32B(+5.2%) | $53.32B(-5.5%) |
| Sep 2013 | - | $56.41B(-0.6%) |
| Jun 2013 | - | $56.77B(+12.2%) |
| Mar 2013 | - | $50.59B(-0.1%) |
| Dec 2012 | $50.67B(+5.2%) | $50.67B(+5.4%) |
| Sep 2012 | - | $48.09B(+0.5%) |
| Jun 2012 | - | $47.85B(-0.7%) |
| Mar 2012 | - | $48.20B(+0.0%) |
| Dec 2011 | $48.19B(-1.6%) | $48.19B(-1.5%) |
| Sep 2011 | - | $48.94B(+1.4%) |
| Jun 2011 | - | $48.27B(-1.5%) |
| Mar 2011 | - | $49.03B(+0.1%) |
| Dec 2010 | $48.98B(-3.6%) | $48.98B(+1.0%) |
| Jun 2010 | - | $48.50B(-5.4%) |
| Mar 2010 | - | $51.25B(+0.8%) |
| Dec 2009 | $50.83B(+95.3%) | $50.83B(+117.3%) |
| Sep 2009 | - | $23.39B(-12.3%) |
| Jun 2009 | - | $26.67B(+8.7%) |
| Mar 2009 | - | $24.54B(-5.7%) |
| Dec 2008 | $26.03B(-6.2%) | $26.03B(-1.9%) |
| Sep 2008 | - | $26.54B(+7.0%) |
| Jun 2008 | - | $24.79B(-1.2%) |
| Mar 2008 | - | $25.08B(-9.6%) |
| Dec 2007 | $27.76B(+12.8%) | $27.76B(+23.1%) |
| Sep 2007 | - | $22.54B(+1.1%) |
| Jun 2007 | - | $22.30B(+1.0%) |
| Mar 2007 | - | $22.08B(-10.3%) |
| Dec 2006 | $24.60B | $24.60B(+11.9%) |
| Sep 2006 | - | $22.00B(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $21.77B(-1.6%) |
| Mar 2006 | - | $22.14B(-9.5%) |
| Dec 2005 | $24.46B(+6.9%) | $24.46B(+3.6%) |
| Sep 2005 | - | $23.61B(+1.7%) |
| Jun 2005 | - | $23.21B(+0.8%) |
| Mar 2005 | - | $23.03B(+0.7%) |
| Dec 2004 | $22.88B(+8.4%) | $22.88B(+5.8%) |
| Sep 2004 | - | $21.63B(+3.1%) |
| Jun 2004 | - | $20.97B(-2.3%) |
| Mar 2004 | - | $21.46B(+1.7%) |
| Dec 2003 | $21.10B(-13.7%) | $21.10B(-9.1%) |
| Sep 2003 | - | $23.21B(-12.0%) |
| Jun 2003 | - | $26.36B(+1.3%) |
| Mar 2003 | - | $26.02B(+6.5%) |
| Dec 2002 | $24.43B(+5.6%) | $24.43B(-1.9%) |
| Sep 2002 | - | $24.89B(+2.8%) |
| Jun 2002 | - | $24.22B(+0.2%) |
| Mar 2002 | - | $24.18B(+4.5%) |
| Dec 2001 | $23.13B(+15.3%) | $23.13B(-1.2%) |
| Sep 2001 | - | $23.41B(+6.3%) |
| Jun 2001 | - | $22.03B(+7.7%) |
| Mar 2001 | - | $20.45B(+1.9%) |
| Dec 2000 | $20.06B(+5.9%) | $20.06B(+3.0%) |
| Sep 2000 | - | $19.47B(-1.2%) |
| Jun 2000 | - | $19.71B(+5.5%) |
| Mar 2000 | - | $18.68B(-1.3%) |
| Dec 1999 | $18.93B(+23.4%) | $18.93B(+6.0%) |
| Sep 1999 | - | $17.86B(+8.1%) |
| Jun 1999 | - | $16.52B(+8.6%) |
| Mar 1999 | - | $15.22B(-0.8%) |
| Dec 1998 | $15.35B(+28.2%) | $15.35B(+2.6%) |
| Sep 1998 | - | $14.95B(+18.3%) |
| Jun 1998 | - | $12.64B(+5.1%) |
| Mar 1998 | - | $12.03B(+0.4%) |
| Dec 1997 | $11.98B(+19.6%) | $11.98B(+1.2%) |
| Sep 1997 | - | $11.83B(+12.5%) |
| Jun 1997 | - | $10.51B(+4.3%) |
| Mar 1997 | - | $10.08B(+0.7%) |
| Dec 1996 | $10.01B(+2.1%) | $10.01B(-2.5%) |
| Sep 1996 | - | $10.27B(+6.9%) |
| Jun 1996 | - | $9.60B(-4.3%) |
| Mar 1996 | - | $10.03B(+2.3%) |
| Dec 1995 | $9.81B(+3.2%) | $9.81B(+1.6%) |
| Sep 1995 | - | $9.65B(+6.0%) |
| Jun 1995 | - | $9.11B(-2.8%) |
| Mar 1995 | - | $9.37B(-1.4%) |
| Dec 1994 | $9.51B(+8.5%) | $9.51B(+10.5%) |
| Sep 1994 | - | $8.61B(+0.2%) |
| Jun 1994 | - | $8.59B(+2.8%) |
| Mar 1994 | - | $8.36B(-4.6%) |
| Dec 1993 | $8.76B(+60.6%) | $8.76B(+39.5%) |
| Sep 1993 | - | $6.28B(-6.0%) |
| Jun 1993 | - | $6.68B(+17.1%) |
| Mar 1993 | - | $5.71B(+4.6%) |
| Dec 1992 | $5.46B(+36.8%) | $5.46B(+13.6%) |
| Sep 1992 | - | $4.80B(+13.6%) |
| Jun 1992 | - | $4.23B(+6.5%) |
| Mar 1992 | - | $3.97B(-0.4%) |
| Dec 1991 | $3.99B(+9.4%) | $3.99B(+0.3%) |
| Sep 1991 | - | $3.98B(+6.6%) |
| Jun 1991 | - | $3.73B(+1.3%) |
| Mar 1991 | - | $3.68B(+1.0%) |
| Dec 1990 | $3.65B(+33.7%) | $3.65B(+4.1%) |
| Sep 1990 | - | $3.50B(+10.1%) |
| Jun 1990 | - | $3.18B(+8.4%) |
| Mar 1990 | - | $2.94B(+7.7%) |
| Dec 1989 | $2.73B(-16.7%) | $2.73B(+2.4%) |
| Sep 1989 | - | $2.66B(-18.6%) |
| Dec 1988 | $3.27B(-8.2%) | $3.27B(-8.2%) |
| Dec 1987 | $3.56B(+40.5%) | $3.56B(+40.5%) |
| Dec 1986 | $2.54B(+11.8%) | $2.54B(+11.8%) |
| Dec 1985 | $2.27B(+10.8%) | $2.27B(+10.8%) |
| Dec 1984 | $2.05B | $2.05B |
FAQ
- What is Merck & Co annual total liabilities?
- What is the all time high annual total liabilities for Merck & Co?
- What is Merck & Co annual total liabilities year-on-year change?
- What is Merck & Co quarterly total liabilities?
- What is the all time high quarterly total liabilities for Merck & Co?
- What is Merck & Co quarterly total liabilities year-on-year change?
What is Merck & Co annual total liabilities?
The current annual total liabilities of MRK is $70.73B
What is the all time high annual total liabilities for Merck & Co?
Merck & Co all-time high annual total liabilities is $70.73B
What is Merck & Co annual total liabilities year-on-year change?
Over the past year, MRK annual total liabilities has changed by +$1.69B (+2.45%)
What is Merck & Co quarterly total liabilities?
The current quarterly total liabilities of MRK is $70.73B
What is the all time high quarterly total liabilities for Merck & Co?
Merck & Co all-time high quarterly total liabilities is $72.97B
What is Merck & Co quarterly total liabilities year-on-year change?
Over the past year, MRK quarterly total liabilities has changed by $0.00 (0.00%)